Previously, we have shown that treatment of an NSCLC mouse xenograft model with the alcohol dehydrogenase inhibitor gossypol or mitochondrial complex I inhibitor phenformin led to only modest tumor regression, but combined treatment with both drugs led to marked synergistic tumor regression [10]. The gene discussed is AKR1A1; the disease is neoplasm.